Galena Biopharma (GALE) Closes 9.75M Common Offering
Tweet
Share
E-mailGet Alerts GALE Hot Sheet
Join SI Premium – FREE
Galena Biopharma (Nasdaq: GALE), has closed the previously announced underwritten public offering of 9,751,500 shares of its common stock at a price to the public of $1.50 per share for gross proceeds of approximately $14.5 million.
The shares include 1,251,000 shares of common stock sold pursuant to the over-allotment option granted by the Company to the underwriters. The net proceeds from the sale of the shares, after deducting the underwriters' discounts and other estimated offering expenses payable by Galena Biopharma, will be approximately $13.3 million.
The shares include 1,251,000 shares of common stock sold pursuant to the over-allotment option granted by the Company to the underwriters. The net proceeds from the sale of the shares, after deducting the underwriters' discounts and other estimated offering expenses payable by Galena Biopharma, will be approximately $13.3 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pyxis Oncology (PYXS) files for 39.2M share offering by selling stockholders
- SharonAI Holdings (SHAZ) files for 8.06M share offering by selling stockholders
- Exchange Bank declares Q3 dividend, CEO to retire in 2027
Create E-mail Alert Related Categories
Corporate News, Equity OfferingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
